Phentermine and tirzepatide together represent an off-label combination approach to weight management that some clinicians consider for patients who have not achieved adequate results with monotherapy
Integration with medicine As evidence accumulates, mainstream medicine may increasingly incorporate peptide therapies
Combining it with another incretin agonist compounds GI and hypoglycemia risk with no supporting evidence, so the documented protocol is monotherapy
, Furthermore, while there was an increase in reports of suicidal ideation and depression in patients taking GLP-1 medications, there was no clear evidence that the GLP-1 medication was the cause
For example: In his 2018 AMA #2 he mentioned taking Atorvastatin and Ezetimibe
Having an adequate blood level of vitamin D when starting a GLP-1 medication may slightly improve outcomes, according to a recent study